These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30949429)

  • 1. Chronic myelomonocytic leukemia as a transformation from polycythemia vera.
    Andrei M; Pandey A; Avezbakiyev B; Wang JC
    Leuk Res Rep; 2019; 11():14-16. PubMed ID: 30949429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center].
    Qu SQ; Pan LJ; Qin TJ; Xu ZF; Li B; Wang HJ; Sun Q; Jia YJ; Li CW; Cai WY; Gao QY; Jiao M; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):373-379. PubMed ID: 37550186
    [No Abstract]   [Full Text] [Related]  

  • 3. Utility of JAK2 V617F allelic burden in distinguishing chronic myelomonocytic Leukemia from Primary myelofibrosis with monocytosis.
    Hu Z; Ramos CEB; Medeiros LJ; Zhao C; Yin CC; Li S; Hu S; Wang W; Thakral B; Xu J; Verstovsek S; Lin P
    Hum Pathol; 2019 Mar; 85():290-298. PubMed ID: 30447300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocytosis in polycythemia vera: Clinical and molecular correlates.
    Barraco D; Cerquozzi S; Gangat N; Patnaik MM; Lasho T; Finke C; Hanson CA; Ketterling RP; Pardanani A; Tefferi A
    Am J Hematol; 2017 Jul; 92(7):640-645. PubMed ID: 28370365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation by Flow Cytometry of Mature Monocyte Subpopulations for the Diagnosis and Follow-Up of Chronic Myelomonocytic Leukemia.
    Picot T; Aanei CM; Flandrin Gresta P; Noyel P; Tondeur S; Tavernier Tardy E; Guyotat D; Campos Catafal L
    Front Oncol; 2018; 8():109. PubMed ID: 29707521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloproliferative Neoplasms with Monocytosis.
    Morsia E; Gangat N
    Curr Hematol Malig Rep; 2022 Feb; 17(1):46-51. PubMed ID: 34773576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexistence of Chronic Myelomonocytic Leukemia and Ulcerative Colitis With Rapid Progression to Acute Myelomonocytic Leukemia: A Case Report.
    Pelkey LJ; Graham DM; Zakem MH; Muza-Moons MM
    Cureus; 2022 Feb; 14(2):e22422. PubMed ID: 35228982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational Landscape of Patients Referred for Elevated Hemoglobin Level.
    Bhai P; Chin-Yee B; Pope V; Cheong I; Matyashin M; Levy MA; Foroutan A; Stuart A; Hsia CC; Lin H; Sadikovic B; Chin-Yee I
    Curr Oncol; 2022 Sep; 29(10):7209-7217. PubMed ID: 36290845
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like Phenotype.
    Heibl S; Gisslinger B; Jäger E; Barna A; Gurbisz M; Stegemann M; Bettelheim P; Machherndl-Spandl S; Pfeilstöcker M; Nösslinger T; Uyanik G; Hoermann G; Stauder R; Thaler J; Kusec R; Valent P; Gisslinger H; Geissler K
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32674283
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Kwon A; Ibrahim I; Le T; Jaso JM; Weinberg O; Fuda F; Chen W
    Leuk Res Rep; 2022; 17():100323. PubMed ID: 35586707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia.
    Federmann B; Abele M; Rosero Cuesta DS; Vogel W; Boiocchi L; Kanz L; Quintanilla-Martinez L; Orazi A; Bonzheim I; Fend F
    Hum Pathol; 2014 Dec; 45(12):2471-9. PubMed ID: 25305095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia.
    Geyer JT; Tam W; Liu YC; Chen Z; Wang SA; Bueso-Ramos C; Oak J; Arber DA; Hsi E; Rogers HJ; Levinson K; Bagg A; Hassane DC; Hasserjian RP; Orazi A
    Mod Pathol; 2017 Sep; 30(9):1213-1222. PubMed ID: 28548124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia.
    Pérez B; Kosmider O; Cassinat B; Renneville A; Lachenaud J; Kaltenbach S; Bertrand Y; Baruchel A; Chomienne C; Fontenay M; Preudhomme C; Cavé H
    Br J Haematol; 2010 Dec; 151(5):460-8. PubMed ID: 20955399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte subsets to differentiate chronic myelomonocytic leukemia from reactive monocytosis.
    Hwang SM; Ahn H; Jeon S; Park J; Chang Y; Kim H
    J Clin Lab Anal; 2021 Jan; 35(1):e23576. PubMed ID: 32931067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Polycythemia Vera Evolve from Acute Myeloid Leukemia? Report of a Case Showing a Simultaneous Minor
    Borsellino B; Savi A; Pascale MR; Meddi E; Del Principe MI; Cristiano A; Ottone T; Rapanotti MC; Divona M; Travaglini S; Attardi E; Palmieri R; Buzzatti E; Buccisano F; Voso MT
    Mediterr J Hematol Infect Dis; 2022; 14(1):e2022058. PubMed ID: 35865394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent of hematopoietic involvement by TET2 mutations in JAK2V⁶¹⁷F polycythemia vera.
    Swierczek SI; Yoon D; Bellanné-Chantelot C; Kim SJ; Saint-Martin C; Delhommeau F; Najman A; Prchal JT
    Haematologica; 2011 May; 96(5):775-8. PubMed ID: 21273266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.
    Gelsi-Boyer V; Trouplin V; Roquain J; Adélaïde J; Carbuccia N; Esterni B; Finetti P; Murati A; Arnoulet C; Zerazhi H; Fezoui H; Tadrist Z; Nezri M; Chaffanet M; Mozziconacci MJ; Vey N; Birnbaum D
    Br J Haematol; 2010 Nov; 151(4):365-75. PubMed ID: 20880116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycythemia vera: scientific advances and current practice.
    Tefferi A; Spivak JL
    Semin Hematol; 2005 Oct; 42(4):206-20. PubMed ID: 16210034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia.
    Bellucci S; Michiels JJ
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):381-98. PubMed ID: 16810614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia.
    Cui Y; Tong H; Du X; Li B; Gale RP; Qin T; Liu J; Xu Z; Zhang Y; Huang G; Jin J; Fang L; Zhang H; Pan L; Hu N; Qu S; Xiao Z
    Exp Hematol Oncol; 2015; 4():14. PubMed ID: 26019984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.